Mira Pharmaceuticals MIRA Cash Flow Statement (2022-2026)

NASDAQ MIRA
$0.62 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Mira Pharmaceuticals Quarterly Cash Flow Statement

Periods 16 quarters
Latest Mar 2026

Mira Pharmaceuticals reported cash from operations of -$1.20M and free cash flow of -$1.20M for the quarter ended Mar 2026, up 26.3% year over year. This cash flow statement covers 16 quarters of results from Jun 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income -2.42M-1.81M-1.35M-1.34M-1.27M-3.59M-5.79M-1.72M-1.69M-2.04M-2.40M-1.78M-1.54M-1.14M-5.94M-1.20M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges 0.44M
Share-based CompensationStock Comp. 0.15M0.15M0.15M0.74M1.45M0.21M0.50M0.60M0.27M0.55M0.87M0.53M0.40M4.51M0.11M
Gains from Investment SecuritiesGains Investment 0.18M-0.21M-0.09M
Change in Working Capital
Change in Accrued ExpensesChange Accrued Exp. 0.35M0.17M0.18M-0.45M0.12M-0.24M0.10M0.15M-0.09M0.03M-0.62M0.19M-0.21M0.05M-0.10M
Change in Other Operating AssetsOther Assets Change 0.00M0.06M-0.02M0.16M0.05M-0.07M-0.08M-0.02M-0.03M0.10M-0.06M-0.04M-0.03M-0.01M
Other Working Capital ChangesOther WC Changes 0.00M-0.06M0.02M-0.16M-0.05M0.07M0.08M0.02M0.03M-0.10M0.06M0.04M0.03M0.01M
Cash from OperationsCash from Ops. -1.31M-0.98M-1.08M-0.66M-1.76M-1.04M-1.05M-0.86M-1.84M-1.81M-1.63M-0.80M-1.10M-1.17M-1.20M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 1.05M
Long-Term Debt RepaymentsLT Debt Repayment 0.05M1.01M0.33M
Net Long-Term Debt Issued (Repaid)Net LT Debt -0.05M0.04M-0.33M
Short-Term Debt issuancesST Debt Issuance 0.09M
Net Short-Term Debt Issued (Repaid)Net ST Debt 0.09M
Net Debt Issuances and RepaymentsNet Debt Issuance -0.05M0.09M0.04M-0.33M
Change in Capital Stock
Common Stock IssuedStock Issued 0.90M0.29M-0.40M3.23M-0.72M0.00M0.35M3.12M4.43M
Net Shares Issued and RepurchasedNet Shares Issued 0.90M0.29M-0.40M3.23M-0.72M0.00M0.35M3.12M4.43M
Net Equity Issued and RepurchasedNet Equity Issued 0.90M0.29M-0.40M3.23M-0.72M0.00M0.35M3.12M4.43M
Other financing activities (as filed) 0.00M-0.05M-0.16M0.35M-0.02M0.01M0.05M-0.11M-0.16M
Cash from Financing ActivitiesCash from Financing 0.68M1.14M0.73M0.68M7.60M-0.23M-0.02M0.16M3.16M0.49M0.00M0.32M3.01M4.84M-0.33M
Additional items
Change in Cash -0.64M0.16M-0.35M0.02M5.84M-1.27M-1.07M-0.70M1.32M-1.31M-1.63M-0.48M1.91M3.71M-1.53M
Ending Cash Balance 0.83M0.19M0.35M0.00M0.02M5.87M4.60M3.53M2.82M4.14M2.83M1.21M0.73M2.64M6.35M4.82M
Free Cash FlowFCF -1.31M-0.98M-1.08M-0.66M-1.76M-1.04M-1.05M-0.86M-1.84M-1.81M-1.63M-0.80M-1.10M-1.17M-1.20M
Net Cash FlowNCF -0.64M0.16M-0.35M0.02M5.84M-1.27M-1.07M-0.70M1.32M-1.31M-1.63M-0.48M1.91M3.67M-1.53M

Mira Pharmaceuticals Cash Flow Statement API

Pull Mira Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MIRA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY